GATA3 Encapsulated by Tumor-Associated Macrophage-Derived Extracellular Vesicles Promotes Immune Escape and Chemotherapy Resistance of Ovarian Cancer Cells by Upregulating the CD24/Siglec-10 Axis-Reference-Cited by-同舟云学术

GATA3 Encapsulated by Tumor-Associated Macrophage-Derived Extracellular Vesicles Promotes Immune Escape and Chemotherapy Resistance of Ovarian Cancer Cells by Upregulating the CD24/Siglec-10 Axis

Published:2022-12-22 Issue:2 Volume:20 Page:971-986
ISSN:1543-8384
Container-title:Molecular Pharmaceutics
language:en
Short-container-title:Mol. Pharmaceutics

Author:

Chen Chao¹,Zhang Li¹,Ruan Zhengyi¹^ORCID

Affiliation:

1. Department of Obstetrics and Gynecology, Shanghai Ninth People’s Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai 200011, P.R. China

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Pharmaceutical Science,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.molpharmaceut.2c00557

Reference41 articles.

1. Epidemiology of epithelial ovarian cancer

2. The disparate origins of ovarian cancers: pathogenesis and prevention strategies

3. Dysfunctional activity of classical DNA end-joining renders acquired resistance to carboplatin in human ovarian cancer cells

4. Ovarian cancer creates a suppressive microenvironment to escape immune elimination

5. Targeting tumor microenvironment in ovarian cancer: Premise and promise

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The potential of biomimetic nanoparticles for macrophage repolarisation and phagocytosis in tumour immunotherapy;Chemical Engineering Journal;2024-10

2. Unravelling CD24‐Siglec‐10 pathway: Cancer immunotherapy from basic science to clinical studies;Immunology;2024-08-11

3. Extracellular vesicles and macrophages in tumor microenvironment: Impact on cervical cancer;Heliyon;2024-08

4. Advances in immune regulation of the G protein-coupled estrogen receptor;International Immunopharmacology;2024-07

5. Tumor-associated macrophages derived exosomes; from pathogenesis to therapeutic opportunities;International Immunopharmacology;2024-07